Annotations: 1DGN

Domain Annotation: SCOP/SCOPe Classification SCOP-e Database Homepage

Chains	Domain Info	Class	Fold	Superfamily	Family	Domain	Species	Provenance Source (Version)
A	d1dgna_	All alpha proteins	DEATH domain	DEATH domain	Caspase recruitment domain, CARD	Iceberg	human (Homo sapiens ) [TaxId: 9606 ],	SCOPe (2.08)

Domain Annotation: SCOP2 Classification SCOP2 Database Homepage

Chains	Type	Family Name	Domain Identifier	Family Identifier	Provenance Source (Version)
A	SCOP2 Family	CARD-like	8025612	4000308	SCOP2 (2022-06-29)
A	SCOP2 Superfamily	DEATH domain	8037991	3000069	SCOP2 (2022-06-29)

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A	CARD	e1dgnA1	A: alpha arrays	X: DEATH domain	H: DEATH domain (From Topology)	T: DEATH domain	F: CARD	ECOD (1.6)

Domain Annotation: CATH CATH Database Homepage

Chain	Domain	Class	Architecture	Topology	Homology	Provenance Source (Version)
A	1.10.533.10	Mainly Alpha	Orthogonal Bundle	Death Domain, Fas	Death Domain, Fas	CATH (4.3.0)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A	PF00619	Caspase recruitment domain (CARD)	Caspase recruitment domain	Motif contained in proteins involved in apoptotic signaling. Predicted to possess a DEATH (Pfam:PF00531) domain-like fold .	Domain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A	ICEBERG (PROTEASE INHIBITOR)	protein binding binding enzyme binding protease binding caspase binding enzyme regulator activity molecular function inhibitor activity peptidase regulator activity molecular function regulator activity enzyme inhibitor activity cysteine-type endopeptidase inhibitor activity peptidase inhibitor activity endopeptidase regulator activity endopeptidase inhibitor activity protein binding binding enzyme binding protease binding caspase binding enzyme regulator activity molecular function inhibitor activity peptidase regulator activity molecular function regulator activity enzyme inhibitor activity cysteine-type endopeptidase inhibitor activity peptidase inhibitor activity endopeptidase regulator activity endopeptidase inhibitor activity CARD domain binding protein domain specific binding	response to stimulus defense response response to stress inflammatory response multicellular organismal process regulation of cellular process interleukin-1 production cellular biosynthetic process negative regulation of biological process regulation of interleukin-1 beta production negative regulation of cellular metabolic process negative regulation of interleukin-1 beta production negative regulation of interleukin-1 production organic substance metabolic process response to stimulus defense response response to stress inflammatory response multicellular organismal process regulation of cellular process interleukin-1 production cellular biosynthetic process negative regulation of biological process regulation of interleukin-1 beta production negative regulation of cellular metabolic process negative regulation of interleukin-1 beta production negative regulation of interleukin-1 production organic substance metabolic process regulation of cytokine production organic substance biosynthetic process cytokine production negative regulation of cellular process regulation of multicellular organismal process negative regulation of macromolecule metabolic process regulation of biosynthetic process regulation of biological process regulation of interleukin-1 production cellular metabolic process negative regulation of metabolic process biological regulation regulation of cellular metabolic process negative regulation of cytokine production regulation of macromolecule metabolic process gene expression macromolecule biosynthetic process negative regulation of cellular biosynthetic process regulation of cellular biosynthetic process regulation of gene expression negative regulation of gene expression biosynthetic process negative regulation of biosynthetic process interleukin-1 beta production negative regulation of macromolecule biosynthetic process regulation of macromolecule biosynthetic process metabolic process cellular process macromolecule metabolic process negative regulation of multicellular organismal process regulation of metabolic process regulation of apoptotic process apoptotic process regulation of programmed cell death cell death programmed cell death regulation of protein binding regulation of molecular function negative regulation of protein binding negative regulation of binding regulation of binding negative regulation of molecular function regulation of protein maturation negative regulation of proteolysis regulation of catalytic activity negative regulation of catalytic activity protein maturation regulation of primary metabolic process negative regulation of peptidase activity regulation of proteolysis proteolysis zymogen inhibition negative regulation of protein metabolic process regulation of cysteine-type endopeptidase activity regulation of protein metabolic process regulation of peptidase activity primary metabolic process regulation of hydrolase activity regulation of protein processing protein processing negative regulation of cysteine-type endopeptidase activity negative regulation of hydrolase activity negative regulation of protein maturation negative regulation of endopeptidase activity inhibition of cysteine-type endopeptidase activity regulation of endopeptidase activity protein metabolic process organonitrogen compound metabolic process negative regulation of protein processing	protein-containing complex

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A	IPR011029	Death-like domain superfamily	Homologous Superfamily
A	IPR001315	CARD domain	Domain

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A	Pharos: P57730	non-small cell lung carcinoma squamous cell carcinoma atopic eczema

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.